3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Glutamic Acid: new trials by email Literature Review of Glutamic Acid trials Research Report on Glutamic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glutamate for Metabolic Intervention in Coronary Surgery II glutamate infusion, saline infusion - Coronary Artery Bypass Surgery, Postoperative Complications | Phase 3 | Completed | University Hospital, Linkoeping | 321 | 2015-11-15 | 2023-12-04 |
| Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Paclitaxel, Carboplatin, Bevacizumab - Lung Cancer | Phase 3 | Completed | ECOG-ACRIN Cancer Research Group | 1516 | 2010-10-25 | 2023-07-07 |
| Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer glutamic acid, placebo - Kidney Cancer, Leukemia | Phase 3 | Completed | University of South Florida | 250 | 2007-05-01 | 2021-08-11 |
Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Burkitt Lymphoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Heart Failure (1) · Kidney Neoplasms (1) · Leukemia (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Neurotoxicity Syndromes (1) · Peripheral Nervous System Diseases (1) · Postoperative Complications (1) · Sarcoma (1)
ECOG-ACRIN Cancer Research Group (1) · University Hospital, Linkoeping (1) · University of South Florida (1)
United States (2) · Sweden (1)
David R. Freyer, DO, MS (1) · Eric Sandler, MD (1) · Farkas Vanky, MD, PhD (1) · Rolf Svedjeholm, Professor (1) · Scott Bradfield, MD (1) · Suresh Ramalingam, MD (1)
PMID 31361535, PMID 35533197, PMID 37657522, PMID 38252440, PMID 41666849
U10CA081920 (1)